Qingdao Phagepharm Bio-tech Co., Ltd. (Noan), founded in 2017 in Qingdao, is China’s largest industrializer of bacteriophage - based preparations, a groundbreaking antibiotic - alternative pharmaceutical. With more than 220 employees and total assets reaching 2.1 billion yuan, the company has established the nation’s largest repository of drug - resistant bacteria, bacteriophages, and viral strains. It provides innovative biotherapy solutions. These solutions target drug - resistant bacterial infections in livestock, aquaculture, pets, and plants, and also offers relevant medical solutions for human drug - resistant bacterial infections. Recognized as a National High - Tech Enterprise, High - Growth Technology Firm, and Shandong Provincial Gazelle Enterprise, Noan holds 44 authorized national invention patents, 108 national microbial strain preservation certificates, and has over 50 peer - reviewed publications. Its accolades include the Second Prize in the China Innovation and Entrepreneurship Competition, Gold Medal in the China Postdoctoral Innovation Competition, and National Outstanding Innovation Project. Operating China’s first GMP - certified bacteriophage production facility, Noan is committed to promoting healthy farming practices, ensuring food safety, and maintaining its leading position in agricultural biotherapy and relevant medical fields.

Nostrud amet eu ullamco nisi aute in ad minim nostrud adipisicing velit quis. Duis tempor incididunt dolore.

Non laboris consequat cupidatat laborum magna. Eiusmod non irure cupidatat duis commodo amet.

Officia excepteur ullamco ut sint duis proident non adipisicing. Voluptate incididunt anim.